Buy me a coffee
Home › FDA recalls › Brand Name: Tandem t:slim mobile application Product Name: t
CLASS II · ModerateFDA

Tandem Diabetes Care, Inc. recalls Brand Name: Tandem t:slim mobile application Product Name: t:slim Mobile Application

📅 Jul 16, 2026 · 📍 Nationwide
Recalling company
Tandem Diabetes Care, Inc.
Product
Brand Name: Tandem t:slim mobile application Product Name: t:slim Mobile Application, iOS Model/Catalog Number: iOS software version 2.13 Software Version: iOS software version 2.13 UDI-DI: 00389152470740 Component: No
Reason
A beta (early-release) version of the iOS application, version 2.13 (TestFlight) had a software issue preventing successful pairing of the t:slim application with Abbott FreeStyle Libre 3 Plus (FSL3P) continuous glucose monitoring (CGM) sensors, resulting in the insulin pump being unable to establish a near-field communication (NFC) connection with the CGM and requiring FSL3P users to use their t:slim insulin pumps in manual mode. FSL3P users are unable to access their CGM's glucose values from within the t:slim app and cannot use their pumps in automated control (closed-loop) mode, which could lead to users experiencing hypoglycemia or hyperglycemia.
Classification
Class II – may cause temporary or medically reversible health consequences
Recall date
Jul 16, 2026
Reported
Oct 7, 2026
Distribution
US Nationwide distribution.
Status
Ongoing
Quantity
177
Lot / codes
Lot Code: UDI-DI: 00389152470641 Software Version: 2.13 (iOS only)
Company location
San Diego, CA
Recall type
Voluntary: Firm initiated
Recall number
Z-3330-2026
Agency
U.S. Food and Drug Administration (FDA)

View official FDA notice ↗ Search recall number Z-3330-2026 in the FDA Enforcement Report. Also see FDA recall press releases.

If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.